|
TBC1D12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.335200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.084630E-01 |
| Normal-vs-Stage2 |
7.572400E-01 |
| Normal-vs-Stage3 |
4.651200E-01 |
| Normal-vs-Stage4 |
6.858800E-01 |
| Stage1-vs-Stage2 |
4.114200E-01 |
| Stage1-vs-Stage3 |
1.073590E-02 |
| Stage1-vs-Stage4 |
9.842000E-02 |
| Stage2-vs-Stage3 |
3.361400E-01 |
| Stage2-vs-Stage4 |
5.400200E-01 |
| Stage3-vs-Stage4 |
7.908400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.292800E-01 |
| Normal-vs-AfricanAmerican |
3.470000E-02 |
| Normal-vs-Asian |
1.088760E-01 |
| Caucasian-vs-AfricanAmerican |
1.810270E-02 |
| Caucasian-vs-Asian |
8.049800E-02 |
| AfricanAmerican-vs-Asian |
4.079000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.717400E-01 |
| Normal-vs-Female |
4.670400E-01 |
| Male-vs-Female |
8.949200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.321700E-02 |
| Normal-vs-Age(41-60Yrs) |
6.388400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.926800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.912400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.619300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.170010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.940400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.321200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.662600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.040800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.334250E-02 |
| Classical-VS-Follicular |
6.002600E-01 |
| Classical-VS-Other |
6.483400E-01 |
| Classical-VS-Normal |
1.759010E-01 |
| Tall-VS-Follicular |
9.228100E-02 |
| Tall-VS-Other |
5.056800E-01 |
| Tall-VS-Normal |
2.622000E-01 |
| Follicular-VS-Other |
8.030000E-01 |
| Follicular-VS-Normal |
5.228400E-01 |
| Other-VS-Normal |
9.962400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.248200E-01 |
| Normal-vs-N1 |
2.694800E-01 |
| N0-vs-N1 |
1.569810E-01 |
|
|
